CRVO Company Profile and Key Details

CervoMed Inc. (NASDAQ:CRVO) closed at $3.89 USD, losing -$0.10 (-2.51%) from the previous close of $3.99. The stock is currently mid-range between its 52-week high and low $1.92 and $16.94. With a market capitalization of about $35.99 million, CervoMed Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~-6.23). Key stats such as the average daily volume over the past year has been around 74.76 thousand shares, in line with its 52-week average. Headquartered in Boston, MA, CervoMed Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO John J. Alam, the company employs approximately 15 people and listed since May 23, 2008. CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases.

CRVO has shown weak momentum, losing -7.91% over the past week and -1.27% over the past quarter, though year-to-date performance is down -11.52%. Short-term trend indicators are bullishly aligned (SMA20 -9.09%, SMA50 -31.38%, SMA200 -43.15%). The stock’s 14-day RSI is 36.08 (weak momentum), while the ATR of 0.47 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -74.03% below its high and over 129.17% above its low. Average 10-day trading volume of 126.78 thousand shares is significantly above the 3-month average of 75.97 thousand, indicating heightened recent market interest.

CervoMed Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.11. This means the shares are trading above this model’s fair value.

CervoMed Inc. has 8.70 million shares outstanding. The public float is 5.48 million shares, elevated short interest at 5.66% of float. This equals 331.39 thousand shares. The short ratio is 0.47 days. Institutional investors hold 34.34% of the float. Insiders own 31.4%. BOGER JOSHUA S holds 840.45 thousand shares, Winton Matthew has 15.00 thousand shares and Gregoire Sylvie has 12.50 thousand shares. Over the past six months, insider transactions show net buying. They sold 0.00 shares across 0 transactions.